
Effects of SGLT2 Inhibitors on Cardiovascular and Lower Limb Events in Patients with Type 2 Diabetes: A Nationwide ...
Introduction Sodium-glucose cotransporter 2 inhibitors (SGLT2i) lower blood glucose levels in patients with type 2 diabetes and reduce both mortality and the risk of cardiovascular (CV) diseases, primarily by decreasing the likelihood of hospitalization …